In brief
A recent analysis reveals the U.S. will halt vital vaccine funding while maintaining some assistance for HIV and TB treatments.
The Trump administration has announced plans to withdraw financial backing from Gavi, the organization instrumental in providing essential vaccines for children in low-income countries, which has contributed to saving millions of lives over the last 25 years. In addition to this termination of funding, there will also be a notable reduction in support aimed at combating malaria, a leading cause of death worldwide.This information was disclosed in a substantial 281-page spreadsheet submitted to Congress by the United States Agency for International Development (U.S.A.I.D.), revealing a detailed breakdown of the foreign aid initiatives that will continue versus those that will be discontinued. The New York Times has secured these documents, underscoring the considerable shift away from the U.S.'s longstanding commitment to portraying itself as a compassionate partner in global development and health initiatives, especially regarding infectious diseases that affect millions each year.The cover letter accompanying the spreadsheet reflects a drastic decline in U.S.A.I.D. activities, reporting that the organization’s funding has mostly been scrapped, leaving only 869 of its over 6,000 employees actively working. The administration has chosen to sustain 898 U.S.A.I.D. projects while terminating a staggering 5,341. Among the remaining programs, the total value reaches approximately $78 billion; however, only $8.3 billion consists of funds that are still available for disbursement. This figure, mainly covering long-term awards, indicates a massive reduction from the previous annual expenditure of around $40 billion that U.S.A.I.D. managed.
